CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Nurix Therapeutics (NRIX) Upgraded to Buy: Here's Why

Positive
AI Analysis

Summary

Nurix Therapeutics (NRIX) received an upgrade to Buy rating from analysts. No specific clinical, regulatory, or financial details were provided in the article.

Importance:2/10
Sentiment:
0.60
rating_upgradeanalyst_note
Related Companies

Read the original article

Published by yahoo_finance on September 9, 2026 4:00 PM

Read Original